Join the NJ NY RAPS chapter for a thought-provoking webinar exploring the opportunities and challenges in orphan drug development and approval, featuring perspectives from a clinician-investigator and a regulatory scientist. Presenters will examine how clinical realities intersect with regulatory frameworks, highlighting key considerations in evidence generation, trial design, and approval strategies for therapies targeting small patient populations.
Registration Fees & Deadlines
Member $0| Nonmember: $25
Speakers
Sindhu Ramchandren, MD, MS
Executive Medical Director, Neuroscience, Johnson & Johnson
Catherine Charron, PhD
Global Regulatory Leader, Neuroscience, Johnson & Johnson
Cancellations and Refunds
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to support@raps.org. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Substitutions
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email support@raps.org with the event title, name of the original registrant and the contact information for the new attendee.
Proof of Attendance
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Questions
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email support@raps.org.